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Abstract: Staphylococcal superantigens (sAgs), such as toxic shock syndrome toxin 1 
(TSST-1), induce massive cytokine production, which may result in toxic shock syndrome 
(TSS) and sepsis. Recently, we reported that in vitro studies in human peripheral blood 
mononuclear cells (PBMC) do not reflect the immunological situation of the host, because 
after exposure to superantigens (sAgs) in vivo, mononuclear cells (MNC) leave the 
circulation and migrate to organs, e.g., the spleen, liver and lung. Our experimental model 
of choice is the rabbit because it is comparable to humans in its sensitivity to sAg. T cell 
activation has been assessed by lymphocyte proliferation and IL-2 gene expression after 
in vivo challenge with TSST-1 and the mutant antigens; expression of the genes of 
proinflammatory cytokines were taken as indicators for the inflammatory reaction after the 
combined treatment with TSST-1 and LPS. The question as to whether the biological 
activities of TSST-1, e.g., lymphocyte extravasation, toxicity and increased sensitivity to 
LPS, are mediated by T cell activation or activation by MHC II-only, are unresolved and 
results are contradictory. We have addressed this question by studying these reactions 
in vivo, with two TSST-1 mutants: one mutated at the MHC binding site (G31R) with 
reduced MHC binding with residual activity still present, and the other at the T cell binding 
site (H135A) with no residual function detectable. Here, we report that the mutant G31R 
induced all the biological effects of the wild type sAg, while the mutant with non-functional Toxins 2010, 2  
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TCR binding did not retain any of the toxic effects, proving the pivotal role of T cells in 
this system. 
Keywords: sepsis; inflammation; T cell involvement; superantigens; endotoxin 
 
1. Introduction  
Infections caused by Staphylococcus aureus (S. aureus) represent a health problem of increasing 
importance. Due to the growing prevalence of antibiotic resistance to these bacteria, new treatment 
options are urgently required to combat the disease. The severity of S. aureus sepsis is positively 
associated with staphylococcal toxins with properties of a superantigen (sAg) [1], e.g., TSST-1. In 
contrast to conventional antigens, sAg bind to major histocompatibility complex (MHC) II molecules 
outside the peptide-binding cleft and to the T cell receptor (TCR) variable β chains (Vβ) on the T cell. 
The hypothesis has been put forward that cross-linking MHC II and the TCR induces inflammation 
characterized by a cytokine storm [2].  
A cytokine storm followed by strong inflammation can cause widespread tissue damage and 
multiorgan failure [3,4]. The relatively weak in vivo and in vitro responses to sAg of mice compared 
with humans have been attributed to differences between mouse and human MHC II, thereby 
emphasizing the important role of MHC II [5,6]. 
Several attempts have been undertaken to detoxify TSST-1 by mutating either their TCR binding 
site (e.g., mutation of histidine 135 to alanine) [7] where the MHC binding site remains functional or 
the MHC II binding site (e.g., mutation of glycin 31 to arginine) with functional binding to TCR [8]. 
Results obtained with these mutants or from binding studies were contradictory in part. Some reports 
showed that inhibition of the interaction sAg-TCR could stop excessive inflammation [9,10], whereas 
others underlined the importance of MHC II binding [11]. Whether sAg-MHC II binding or TCR-sAg 
interaction is of decisive importance for activation of innate immunity has to be further clarified. 
Schlievert  et al. showed that streptococcal mutant sAgs lacking residues necessary for T cell 
activation still retained lethality in rabbit models [12]. These authors tested a series of single and 
double mutants showing that the ability of exotoxins to cause lethality and endotoxin enhancement 
does not require superantigenicity. 
Dinges et al. showed that impairment of T cell function by cyclosporin protected rabbits against the 
lethality of toxic shock syndrome (TSS) [13]. In contrast, they showed that total body irradiation could 
not prevent TSS. However, they could not exclude the possibility that the results might have been 
skewed by a small number of radio-resistant T cells. 
Inflammation by LPS is strongly enhanced after priming with sAg [14]. The mechanism responsible 
for this sensitization is not well understood. It has been suggested that the upregulation of TLR4 by 
sAg might be responsible for the enhanced response to LPS [15] as TLR4 is the receptor for LPS and 
this mechanism of innate immunity might be responsible for the overwhelming inflammatory response 
that leads to tissue damage [16]. 
Kum et al. emphasized the importance of sAg/TCR interaction based on in vitro studies. They 
studied the temporal sequence of the cytokine expression pattern in human peripheral blood Toxins 2010, 2  
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mononuclear cells (PBMC) after stimulation with wild type (wt) TSST-1, G31R and H135A. Using 
enzyme-linked immunoabsorbent assays (ELISAs), they showed that G31R induced a cytokine profile 
similar to that of wtTSST-1, while H135A showed complete absence of any cytokine secretion [9]. 
According to our knowledge, the biological effect of these mutants has never been studied in vivo.  
SAgs are known to strongly increase sensitivity to LPS. Rabbits pretreated with even low doses of 
sAg die when exposed to low amounts of LPS [13]. The mechanism of this amplification is still 
poorly understood.  
In our studies, using the mutant toxins G31R and H135A in vivo, we explored whether, in addition 
to MHC class II binding, T cell binding was mandatory for the sensitization for LPS.  
Recently, applying quantitative real time PCR (qRT-PCR) and proliferation assays, we detected cell 
activation and strong induction of cytokine gene expression in the organs of rabbits soon after sAg 
administration. This activation could not be detected in the periphery [17]. Therefore, results obtained 
from the circulation do not accurately reflect the immunological state of the host.  
Here we studied those biological effects of staphylococcal toxins (superantigens) of which the 
mechanisms of action are not well understood. We applied the mutants G31R and H135A and prove 
that T cell activation is mandatory for both Vβ unrestricted extravasation and for the sensitization 
for LPS.  
2. Results and Discussion 
2.1. G31R induces leukopenia, lymphopenia and monocytopenia in rabbits. In contrast, no effect on 
MNC subsets by H135A  
Rabbits were studied in terms of their leukocyte and lymphocyte counts after administration of the 
TSST-1 mutants G31R and H135A. To compare the induced effects with the ones elicited by the wt 
protein, we used TSST-1 as a positive control. Negative control rabbits were only injected with PBS. 
Prior to injection, WBC of rabbits (n = 20) tested were 6150 ± 1905 cells/µL (AV ± SD). After 
application of G31R, the number of circulating leukocytes started to decline and decreased to 
2171 ± 378 cells/µL (AV ± SD)  6 h  after  injection  (Figure 1A). Thus, the counts of WBC were 
comparable to the levels reached 6 h after TSST-1 application (1913 ± 688 cells/µL). The leukocytes 
within the circulation returned to baseline levels already 24 h after G31R injection which was slightly 
earlier than after TSST-1 application. No significant changes were observed in H135A-treated rabbits 
or in the controls (Figure 1A). Similar results were obtained with total lymphocyte counts after 
administration of G31R, TSST-1 versus H135A and PBS (Figure 1B). 
Flow cytometric studies of different lymphocyte subsets revealed that the effects at G31R on the 
number of CD4
+ and CD8
+ T cells as well as CD14
+ and IgM
+ cells within the circulation were 
comparable to the effects induced by TSST-1 (Figure 1C-1F). However, after G31R injection, cell 
counts of the studied subsets increased earlier as compared to TSST-1 suggesting a 
quantitative difference.  
These results indicate extravasation of monocytes and lymphocytes by G31R comparable to TSST-1, 
while no effect was observed after injection of H135A under identical conditions (Figure 1A–1F). Toxins 2010, 2  
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Figure 1. (a–f) Significant decrease of CD4
+, CD8
+, IgM
+ and CD14
+ cells in the 
circulation of rabbits injected with G31R or TSST-1. No influence on cell counts of WBC 
and subsets after application of H135A. Rabbits were injected with either 100 µg G31R  
(n = 6) [●] or 100 µg H135A (n = 6) [□]. The positive controls received TSST-1 (n = 4) [▲], 
PBS (n = 4) [X] and the negative controls received PBS (n = 4) [X]. Prior to application, as 
well as 1 h, 2 h, 6 h, 24 h and 48 h after injection, the numbers of WBC (a) and total 
lymphocytes (b) were determined from venous blood of rabbits. The absolute numbers of 
the lymphocyte subsets (c) CD4
+, (d) CD8
+, (e) IgM
+ and (f) CD14
+ were calculated from 
FACS analyses at the time points denoted, as described in Materials and Methods. Figures 
(c–f) show mean values ± SD of the numbers of the indicated cell populations of 4 rabbits 
injected with G31R, and of 4 rabbits administered by H135A. Mean ± SD of positive and 
negative control rabbits were calculated from 4 experiments. 
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Figure 1. Cont. 
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Figure 1. Cont. 
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2.2. T cell activation by proliferation assays in human PBMCs can be detected after stimulation with 
wtTSST-1 and G31R but not with H135A 
The mitogenic effects of TSST-1 and several mutants of TSST-1 have been studied in several 
species. Furthermore, TSST-1 and the mutants G31R and H135A have been compared in terms of their 
T cell activation by monitoring the percentage of Vβ2
+ CD25
+ expressing cells in flow cytometry 
studies [27]. Here, we compare the dose response of T cell activation by measuring the proliferative 
capacity of human PBMC. We found that G31R significantly stimulated the proliferation of T cells in 
a range from 10 µg/mL–1 ng/mL as compared to medium. This was lower than proliferation induced 
by TSST-1, whereas H135A was devoid of mitogenic capacity in the whole range (Figure 2). 
Figure 2. T cell activation and proliferation of human PBMC is induced by G31R and 
TSST-1. No proliferation of human PBMC after stimulation with H135A. Human PBMC 
derived from healthy donors were cultured for 5 days in the presence of the indicated 
concentrations of TSST-1 (n = 4, black bars), G31R (n = 6, hatched bars) and H135A  
(n = 4, open bars). Columns represent mean values ± SD of dpm as a measure of 3H-thymidine 
uptake of cells. As a positive control, PBMC were stimulated by PHA.  
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2.3. IL-2 expression is induced in the organs after administration of wtTSST-1 and G31R but not after 
administration of H135A 
Injection of G31R resulted in an induction of IL-2 gene expression in the spleen (Figure 3). The 
induction of IL-2 gene expression was similar after application of wtTSST-1. By contrast, no induction 
of IL-2 gene expression was noted in the spleen when H135A was given.  
Figure 3. IL-2 gene activation in the spleen after administration of TSST-1 and G31R. 
Rabbits were challenged with G31R, wtTSST-1, and H135A for 4h and the spleen was 
extracted as described in Materials and Methods. IL-2 expression was determined via real 
time PCR and was related to the expression of the house-keeping gene GAPDH by 
dividing the IL-2 mRNA copy numbers through the mRNA copy numbers of GAPDH. 
 
2.4. TSST-1 and G31R induce inflammatory cytokines in the organs 
As previously shown [17], cytokine gene expression is significantly induced in the organs after 
application of TSST-1. Here we addressed the question whether the mutants of TSST-1 induced 
different cytokine profile compared to that of the wildtype. 
Figure 4A shows the cytokine expression in the spleen after administration of G31R. We detected a 
cytokine expression pattern similar to that observed after application of TSST-1. IL-6 (black bars) was 
strongly induced (500-fold) and also IFNγ gene expression (hatched bars) was significantly enhanced 
(50-fold). IL-1β (white bars) and TNFα (grey bars) were slightly increased (6-fold and   
5-fold, respectively). 
The induction levels after administration of TSST-1 were comparable (Figure 4B). IL-6 (black bar) 
was most strongly induced (400-fold) but also IFNγ (hatched bar) was significantly induced   
(100-fold). Inductions of IL-1β (white bar; 24-fold) and TNFα (grey bar; 7-fold) were less. Induction 
of gene expression was also observed in other organs (liver, lung) but it was considerably less than in 
the spleen (data not shown). 
By contrast, application of H135A did not significantly increase any cytokine expression (Figure 4c). Toxins 2010, 2  
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Figure 4. (a–c) The expression of proinflammatory cytokines is induced in the spleens of 
rabbits after a challenge with G31R and wt TSST-1. Rabbits were challenged for 4 h and 
the expression of the proinflammatory cytokines was measured in the spleen by real time 
PCR. (a) G31R and (b) TSST-1 strongly increase the expression of IL-6 (black bars, ■) 
and IFNγ (hatched bars,  ). Induction of IL-1β (white bars, □) and TNFα (grey bars,  ) 
was weak (6-fold and 5-fold). (c) H135A did not cause an induction of cytokines. 
(a).       (b). 
 
(c). 
 
2.5. G31R- and H135A- pre-priming differ in the induction of the cytokine storm after LPS triggering  
LPS administration after TSST-1 priming leads to a cytokine storm in the organs. Here we show 
that G31R + LPS (Figure 5A) led to a cytokine storm. IL-6 was induced 3113-fold, IFNγ 871-fold, IL-1β 
and TNFα both 50-fold. These levels were comparable to those observed after TSST-1 + LPS 
treatment (Figure 5B). By contrast, H135A + LPS (Figure 5C) did not give rise to significant cytokine 
gene induction. The induction was slightly stronger than after application of LPS alone (Figure 5D). 
Table 1 summarizes the fold induction levels of the proinflammatory cytokines in the spleen. Toxins 2010, 2  
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Figure 5. (a–d) Pre-priming with TSST-1 leads to a strong enhancement of LPS sensitivity 
and to a subsequent cytokine storm in the spleen. Rabbits were challenged for 4 h with 
wtTSST-1, G31R and H135A followed by administration of LPS for a further 2 h. The 
expression of proinflammatory cytokines was quantified with real time PCR. (a) G31R + LPS 
and (b) TSST-1 + LPS induce an exorbitant expression of pro-inflammatory cytokines, 
particularly of IL-6 (black bars, ■) and IFNγ (hatched bars,  ). IL-1β (white bars, □) and 
TNFα (grey bars,  ) were less induced. There was no induction of cytokines in rabbits 
treated with (c) H135A + LPS in comparison to (d) LPS-challenged animals. 
(a).        (b). 
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2.6. Discussion 
There is general agreement that animal models available at present are sub-optimal for 
understanding the sequence of events in sepsis. Even though it is generally agreed upon that infection 
by one or several microbial agents is responsible for pathogenesis, the diagnosis of sepsis still greatly 
relies on clinical symptoms of inflammation and, in spite of greatly improved methodology in 
microbiology, the identification of an underlying infection, proven by the detection of bacteremia, is 
still lacking in 30–50% of cases.  
Even though the amplification of endotoxins (LPS) of Gram-negative bacteria by exotoxins of 
Gram-positive bacteria (with characteristics of sAg) is clearly established, this notion has not been Toxins 2010, 2  
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taken into consideration in animal models of sepsis. Extensive colonization of the population with 
Gram-positive bacteria and the relevance of the interrelation between colonizing and invasive infection 
in septic patients is well recognized [18].  
Investigation in infants who died of SIDS (Sudden Infant Death Syndrome) revealed that these 
infants were significantly more often, more extensively double colonized with S. aureus [19] and 
E. coli [20]. We have raised the hypothesis that a similar mechanism may be operational in sepsis 
because of the frequent colonization with toxin-producing S. aureus and endotoxin-producing and 
releasing E. coli in the gut. Evidence of considerable contact with toxin-producing staph is provided by 
the fact that over 90% of adults have antibodies to at least one, but usually several, staph toxins.  
TSST-1 potentiates the activity of endogenous endotoxin by inhibiting clearance from the blood [21]. 
We applied the combined treatment of the staph exotoxins, e.g., TSST-1, and endotoxin of 
Gram-negative bacteria, e.g., LPS of E. coli, as our experimental model in order to delineate the 
cellular sequence of the events in this system.  
The rabbit was selected as the species most appropriate for these studies because of its high 
sensitivity to staph sAg. Although most animal studies have been performed in mice, sensitivity of 
mice to these sAg is extremely low. Application of 200 µg/kg of TSST-1 followed by 400 µg/kg of 
LPS was needed to cause a fatality rate of 50% in mice, whereas 10 ng/kg TSST-1 and 10 µg/kg LPS 
were required to bring about a fatality rate of 100% in rabbits [22]. Notably, lethality developed at 
approximately the same peak circulating level of TNFa in mice and rabbits showing that both species 
are equally sensitive to the lethal effects of circulating TNFa. 
Furthermore, exposure to the toxin-producing bacteria and/or the toxin itself causes a disease in 
rabbits similar to human TSS. Therefore, as previously pointed out [17,23], the rabbit model has been 
preferred to answer questions regarding the pathophysiology of TSS.  
In the rabbit model we started to analyze the interrelation between T cell activation and 
inflammation: assessing T cell activation by lymphocyte proliferation and IL-2 gene expression and 
inflammation by activation of the genes of proinflammatory cytokines (IL-6, TNFα, IL-1β and IFNγ).  
In a previous paper, analyzing the effect of TSST-1 in vivo in rabbits, we described that application 
of sAg leads to Vβ-unrestricted migration of MNC from the circulation [17]. Activated cells have been 
detected in organs, e.g., the spleen, the liver and the lung. The compartmentalization of the response 
after exposure to sAg is important but often neglected. Cytokines produced (early) in the organs, such 
as TNFα in the spleen [3,24], might not be detected in the periphery. Other authors described that 
lymphocytes leave the circulation in a Vβ-dependent manner [25]. Thus, mechanisms of this 
extravasation are not well understood in this context. As the migrating cells (activated T cells, B cells, 
and cells of the monocyte macrophage lineage) all express MHC II on their surface, it was unclear 
whether direct interaction between sAg and these cells via MHC II would be sufficient to trigger the 
process. Leukopenia and lymphopenia were described after sAg challenge in different species and 
lymphopenia is also a frequent finding in patients with TSS and septic shock caused by S. aureus. 
Results of experiments with the mutant toxins clearly indicate that sAg-TCR interaction is a mandatory 
step for extravasation. The G31R mutant with the intact TCR binding site induced extravasation of 
lymphocytes comparable to TSST-1 (Figure 1). In contrast, the mutant H135A with intact MHC II 
binding, but defect in TCR interaction, had no effect (Figure 1). Our analysis of the mutants G31R and Toxins 2010, 2  
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H135A confirmed the results of Kum et al. [9] describing that the mutant G31R induced significant  
T cell activation, albeit of lower magnitude than TSST-1 in human MNC.  
Table 1. Fold induction levels of proinflammatory cytokines in the spleen after 
administration of sAg, LPS or the combination. 
Cytokine  Toxin  Fold induction 
IL-6 TSST-1  401 
IL-6 G31R  499 
IL-6 H135A  3 
IL-6  TSST-1 + LPS  4547 
IL-6  G31R + LPS  3113 
IL-6  H135A + LPS  907 
IL-6 LPS  268 
   
IFNγ TSST-1  107 
IFNγ G31R  44 
IFNγ H135A  0 
IFNγ  TSST-1 + LPS  850 
IFNγ  G31R + LPS  871 
IFNγ  H135A + LPS  120 
IFNγ LPS  124 
   
IL-1β TSST-1  24 
IL-1β G31R  6 
IL-1β H135A  0 
IL-1β  TSST-1 + LPS  90 
IL-1β  G31R + LPS  44 
IL-1β  H135A + LPS  5 
IL-1β LPS  11 
   
TNFα TSST-1  7 
TNFα G31R  5 
TNFα H135A  1 
TNFα  TSST-1 + LPS  26 
TNFα  G31R + LPS  39 
TNFα  H135A + LPS  7 
TNFα LPS  4 
Cells activated by sAg migrate from the circulation to the organs, e.g., the spleen and the liver. IL-2 
gene expression could be detected early after TSST-1 challenge mainly in the spleen of rabbits [17]. 
Similarly, T cells from the spleen were described to be the source of early TNFα in response to SEB in 
D-galactosamine-sensitized mice [3].  
Here, we report induction of IL-2 gene expression in the spleen of rabbits treated with G31R and 
wtTSST-1 while no increased expression could be detected with H135A. These findings led us to ask 
the question whether T cell activation, i.e., IL-2 gene expression, is correlated with the amplification of Toxins 2010, 2  
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the inflammatory response induced by LPS. To the best of our knowledge, there are no in vivo reports 
available describing that rabbits pre-treated with TSST-1 reacted with a cytokine storm in the organs 
when LPS was given later. Induction of proinflammatory cytokine genes, mainly IL-6 but also IFNγ, 
IL-1β and TNFα, was higher than observed after treatment with either toxin alone. These 
proinflammatory cytokines are mainly produced by non-T cells, mainly macrophages and dendritic 
cells. The results clearly indicate that the primary signal is given by T cells leading to activation of IL-6 
expression by macrophages and dendritic cells. It has been shown in mouse [15] in vivo and in human 
cells in vitro [26] that sAgs enhance the TLR4 expression on monocytes. We also observed a slight 
increase of TLR4 gene expression in rabbits and mice following administration of TSST-1 
(unpublished results). This enhanced expression of TLR4 may be responsible for the augmented 
susceptibility to its ligand LPS.  
Moreover, sAg may also modulate the interaction between staph and other entities of innate 
immunity, e.g., TLR2, which may be of importance in clearing staph infections. 
The mutant H135A did not induce T cell proliferation or IL-2 gene expression. Thus, this mutant 
did not have the potential for T cell activation. This mutant did not induce extravasation of 
lymphocytes and monocytes, nor did it sensitize for the LPS-triggered cytokine burst, proving that T-cell 
activation is mandatory for these biological effects. Even though the combined effect of sAg and LPS 
has rarely been studied, and not in the same system, these results are in agreement with the report of 
Kum et al. [9] and differ from the studies of Roggiani et al. [16]. The reason for this difference could 
be explained by the different sAg applied (streptococcal versus staphylococcal) and by the different 
experimental setup. Other studies drew their conclusions from in vitro experiments [9] or from studies 
performed in mice [27] or rats [28]. 
3. Experimental Section  
3.1. Animals 
New Zealand white female rabbits 1.5–2 kg were purchased from Charles River Laboratories 
(Sulzfeld, Germany). Animals were kept in standard care facilities according to the guidelines of the 
Austrian Ministry for Science and Research and had free access to food (Altromin 2120 standard diet 
pellets; Marek Futtermittelwerke, Vienna, Austria) and water. The animal experiments had been 
approved and controlled by the Veterinary Department of the City of Vienna.  
3.2. Injection of the toxins  
100 µg of the wt TSST-1, G31R, H135A and 10µg of LPS were applied for time periods as 
indicated in the figures. The substances were dissolved in 1 mL of PBS, sterile filtered and injected as 
previously described [17]. For control experiments, PBS was either subcutaneously (2 × 0.5 mL) or 
intravenously (1 × 1 mL) administered. 
3.3. Organ extraction, RNA isolation and reverse transcription 
Organ extraction after anaesthesia of rabbits was performed at time points indicated in the figures 
and was extensively described in a previous report [17]. Organs were then homogenized using an Toxins 2010, 2  
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Ultra-Turrax T8 homogenizator (IKA, Staufen, Germany) and RNA was extracted according to the 
protocol of the manufacturer. 900 ng of RNA was reversely transcribed using the 2xRT Kit from 
Invitrogen (Invitrogen, Paisley, UK).  
3.4. Substances 
TSST-1, G31R and H135A were produced in our laboratory. Both the expression and purification 
of TSST-1, G31R and H135A are extensively described by Gampfer et al. [29]. All substances were 
tested for their biological activities in our laboratory and were proven to be endotoxin-free. 
3.5. Antibodies for flowcytometry analyses 
The murine unlabeled or conjugated mAbs recognizing the rabbit cell surface antigens CD4 
(clone: KEN-4), CD8 (clone: 12C7), IgM (clone: NRBM) and CD14 (clone: Tsk4) were purchased 
from Serotec (Oxford, UK). The corresponding IgG1 and IgG2a negative control mAbs were obtained 
from BD Pharmingen (Becton Dickinson, San Jose, CA, USA). 
3.6. Immunofluorescence analyses  
Venous EDTA-whole blood samples drawn before and 1 h, 2 h, 6 h, 24 h and 48 h after injection 
were analyzed for their leukocyte and lymphocyte counts with the help of a Coulter counter machine 
(Beckman Coulter) and a hematology analyzer (Abbott Laboratories, Abbott park, IL, USA) followed 
by flow cytometry. Immunofluorescence analyses were performed as previously described [17]. In 
short, 100 µL whole blood was incubated with mAbs specific for CD4, CD8, CD14, IgM or irrelevant 
isotype-matched mAbs. After incubation, cells were washed and binding of the primary mAb was 
visualized using rabbit F(ab')2 anti-mouse Ig-fluorescein isothiocyanate (FITC) (STAR9B; Serotec). 
Subsequently, cells were lysed, washed and analyzed on a FACS Calibur flow cytometer supported by 
the CELLQUEST software (Becton Dickinson). FACS-data allowed determining the percentage of 
granulocytes and mononuclear cells (MNC) within these whole blood samples by gating cells 
according to their size and granularity. Consequently, absolute granulocyte numbers were calculated. 
The knowledge of the calculated absolute MNC numbers, and the percentage of CD4
+, CD8
+, IgM
+ 
and CD14
+ cells within the MNC population, allowed determination of absolute cell numbers of these 
subpopulations within the whole blood samples. 
3.7. Lymphocyte proliferation assay 
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized blood of healthy 
human adults using density gradient centrifugation with LymphoprepTM (Axis-Shield PoC, Oslo, 
Norway), as previously described [17]. In brief, cells (1 × 10
5 cells/well) were cultured in 96-well 
flat-bottom tissue culture plates (Sarstedt, Newton, NC, USA) in complete medium consisting of 
RPMI 1640 medium (PAA laboratories, Pasching, Austria), 10% FCS (HyClone, Logan, UT, USA), 
2 mM  L-glutamine (Invitrogen, Paisley, UK), 100 U/mL penicillin, and 100 µg/mL streptomycin 
(Invitrogen). PBMC were stimulated in triplicate by rTSST-1, G31R and H135A used in final 
concentrations between 10 µg/mL and 10 pg/mL. As a positive control, phytohaemagglutinin (PHA, Toxins 2010, 2  
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Sigma-Aldrich, St. Louis, MO, USA) were used in the final dilution of 1:320. Stimulated cells were 
cultured for five days in a humidified atmosphere (37 °C, 5% CO2). On day four, 0.5 µCi/well 
3H-thymidine (GE Healthcare, Chalfont St Giles, UK) was added and 18 h later cells were frozen and 
stored at −20 °C until harvesting onto glass fiber filters. Incorporated radioactivity was determined on 
a MicroBeta Trilux 1450 scintillation counter (Wallac, Turku, Finland) and expressed as dpm. 
3.8. Primers 
Gene-specific oligonucleotide primers were designed by hand and by primer design Primer 
Express® v2.0 software from Applied Biosystems (Foster City, CA, USA). Where genomic sequence 
information of rabbit was not available, consensus sequences of the cytokine genes from human and 
mouse served for primer design. Primer pairs were synthesized at MWG Biotech (Heidelberg, 
Germany) and at Invitrogen. 
3.9. Preparation of external cDNA standards 
CDNA standards were prepared as previously described [17] and served for absolute quantification 
of the target samples. 
3.10. QRT-PCR and quantification  
Quantitative Real time PCR has been extensively described [17]. In short, cDNA from samples and 
standards were simultaneously amplified on the same plate using an ABI Prism 7700 (Applied 
Biosystems, Foster City, CA, USA) using the SYBR Green Super Mix from Invitrogen with a ROX 
reference dye. At the end of the amplification, a melting curve analysis was performed. 
The number of target cDNA copy numbers in the cellular samples was then calculated by creating a 
standard curve where the cycles at threshold (CT) were plotted against the logarithmic values of the 
cDNA standard copy number. GAPDH served as an internal standard. Fold induction of gene 
expression was assessed from values normalized for the expression of GAPDH and then related to the 
mean values derived from the spleen of three unchallenged rabbits. 
3.11. Statistical analyses 
Paired t-test has been applied to calculate the significance of the decrease between pre- and 
post-application values of WBC, lymphocytes and lymphocyte subsets. A decrease was considered to 
be significant at a p value ≤ 0.05 and is marked with an asterix. 
Students’ t-test has been applied to evaluate the significance (p ≤ 0.01) in proliferation experiments. 
4. Conclusions  
In conclusion, we prove in vivo that following exposure to sAg, T cell activation is the mandatory 
first step for the inflammatory/toxic effects studied. The most pronounced cause of toxicity is the 
cytokine storm in sepsis and it has been suggested that the cytokine storm is mainly responsible for 
toxicity. The majority of cells involved in the production of proinflammatory cytokines are 
non-T cells, such as B cells and cells of the monocyte/macrophage lineage. Our findings demonstrate Toxins 2010, 2  
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the primary role of T cells in activation and/or triggering of these non-T cell populations. T cells have 
been shown to modulate the inflammatory reaction. The understanding of the mechanism of T cell 
modulation of the inflammatory response in this context is of pivotal importance and is presently under 
investigation in our lab. 
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